Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia

被引：0

作者：

Dongwoo Kang

Elizabeth Ludwig

David Jaworowicz

Hannah Huang

Jill Fiedler-Kelly

Jorge Cortes

Siddhartha Ganguly

Samer Khaled

Alwin Krämer

Mark Levis

Giovanni Martinelli

Alexander Perl

Nigel Russell

Malaz Abutarif

Youngsook Choi

Ophelia Yin

机构：

[1] Daiichi Sankyo,Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V

[2] Inc,Division of Hematology and Oncology, Abramson Cancer Center

[3] Cognigen Corporation,Centre for Clinical Haematology

[4] a Simulations Plus Company,undefined

[5] Georgia Cancer Center at Augusta University,undefined

[6] University of Kansas Cancer Center,undefined

[7] City of Hope,undefined

[8] University of Heidelberg,undefined

[9] The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University,undefined

[10] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,undefined

[11] University of Pennsylvania,undefined

[12] Nottingham University Hospital,undefined

来源：

Cancer Chemotherapy and Pharmacology | 2021年 / 87卷

关键词：

Concentration–QTc analysis; Quizartinib; AC886; Relapsed/refractory; Acute myeloid leukemia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：513 / 523

页数：10

共 50 条

[31] Azacitidine combined with gemtuzumab ozogamicin in patients with relapsed/refractory acute myeloid leukemia
Bayraktar, Ulas Darda
Domingo, Gelenis Calzadilla
Schmit, Jessica
Pereira, Denise
LEUKEMIA & LYMPHOMA, 2011, 52 (05) : 913 - 915
[32] NATIONAL EXPERIENCE WITH THE USE OF VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
Labrador, J.
Saiz-Rodriguez, M.
De Miguel, D.
Vidriales, M. B.
Perez-Encinas, M.
Sanchez-Sanchez, M. J.
Cuello, R.
Roldan-Perez, A.
Vives, S.
Benzo-Callejo, G.
Colorado, M.
Garcia-Fortes, M.
Sayas, M. J.
Olivier, C.
Recio, I
Seri-Merino, C.
Tormo, M.
Vall-llovera, F.
Foncillas, M. A.
Montesinos, P.
HAEMATOLOGICA, 2020, 105 : 56 - 56
[33] A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia
Canaani, Jonathan
Danylesko, Ivetta
Shemtov, Noga
Zlotnick, Maya
Lozinsky, Kira
Benjamini, Ohad
Yerushalmi, Ronit
Nagar, Meital
Dor, Chen
Shimoni, Avichai
Avigdor, Abraham
Nagler, Arnon
EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (02) : 260 - 266
[34] Infections in children with acute myeloid leukemia: increased mortality in relapsed/refractory patients
Zajac-Spychala, Olga
Skalska-Sadowska, Jolanta
Wachowiak, Jacek
Szmydki-Baran, Anna
Hutnik, Lukasz
Matysiak, Michal
Pierlejewski, Filip
Mlynarski, Wojciech
Czyzewski, Krzysztof
Dziedzic, Magdalena
Wysocki, Mariusz
Zalas-Wiecek, Patrycja
Bartnik, Magdalena
Ociepa, Tomasz
Urasinski, Tomasz
Malas, Zofia
Badowska, Wanda
Gamrot-Pyka, Zuzanna
Woszczyk, Mariola
Tomaszewska, Renata
Szczepanski, Tomasz
Irga-Jaworska, Nina
Drozynska, Elzbieta
Urbanek-Dadela, Agnieszka
Karolczyk, Grazyna
Plonowski, Marcin
Krawczuk-Rybak, Maryna
Fraczkiewicz, Jowita
Salamonowicz, Malgorzata
Chybicka, Alicja
Stolpa, Weronika
Sobol-Milejska, Grazyna
Chelmecka-Wiktorczyk, Liliana
Balwierz, Walentyna
Zak, Iwona
Gryniewicz-Kwiatkowska, Olga
Gietka, Aneta
Dembowska-Baginska, Bozenna
Semczuk, Katarzyna
Dzierzanowska-Fangrat, Katarzyna
Musial, Jakub
Chaber, Radoslaw
Kowalczyk, Jerzy
Styczynski, Jan
LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 3028 - 3035
[35] A Phase II Study of Bisantrene in Patients with Relapsed/Refractory Acute Myeloid Leukemia
Canaani, Jonathan
Danilesko, Ivetta
Shem-Tov, Noga
Zlotnick, Maya
Lozinsky, Kira
Benjamini, Ohad
Yerushalmi, Ronit
Nagar, Meital
Dor, Chen
Shimoni, Avichai
Avigdor, Abraham
Nagler, Arnon
BLOOD, 2020, 136
[36] Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (ISAKIDS): Interim Analysis
Baruchel, Andre
Abrahamsson, Jonas
Bertrand, Yves
Gonzalez, Oscar
Nysom, Karsten
Quinones, Willy
Rizzari, Carmelo
Buechner, Jochen
Cesaro, Simone
Duarte, Joaquin
Fagioli, Franca
Kang, Hyoung Jin
Kattamis, Antonis
Leverger, Guy
Ludwig, Kathleen
Makiya, Monica L.
Micalizzi, Concetta
Nelken, Brigitte
Tondel, Camilla
Yoo, Keon Hee
Ivanina, Inna
Brillac, Claire
Wang, Lynn
Oprea, Corina
Abbadessa, Giovanni
Zwaan, C. Michel
BLOOD, 2021, 138
[37] Pharmacokinetics and pharmacodynamics of gilteritinib in patients with relapsed or refractory acute myeloid leukemia.
Smith, Catherine Choy
Levis, Mark J.
Litzow, Mark Robert
Perl, Alexander E.
Altman, Jessica K.
Gill, Stan
Yuen, Geoffrey
Bonate, Peter
Kadokura, Takeshi
James, Angela Joubert
Liu, Charles
Nagase, Itsuro
Fisniku, Ogert
Bahceci, Erkut
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[38] The role of quizartinib in the treatment of acute myeloid leukemia
Ostronoff, Fabiana
Estey, Elihu
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (12) : 1659 - 1669
[39] Use of decitabine for patients with refractory or relapsed acute myeloid leukemia: a systematic review and meta-analysis
Ma, Yuan-yuan
Zhao, Min
Liu, Yi
Zhao, De-feng
Wang, Li-xin
Chen, Xiao-ping
Li, Li
HEMATOLOGY, 2019, 24 (01) : 507 - 515
[40] Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia
Wang, Li
Xu, Jun
Tian, Xiaolong
Lv, Tingting
Yuan, Guolin
ACTA HAEMATOLOGICA, 2019, 141 (01) : 43 - 53

← 1 2 3 4 5 →